Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 4089
TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209580(US9273011, 1 | US10016420, 1)
Affinity DataIC50: 29.6nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209582(US9273011, 3 | US10016420, 3)
Affinity DataIC50: 38nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209581(US9273011, 2 | US10016420, 2)
Affinity DataIC50: 40.3nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209584(US9273011, 5 | US10016420, 5)
Affinity DataIC50: 69.6nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209586(US9273011, 7 | US10016420, 7)
Affinity DataIC50: 89.2nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209587(US9273011, 8 | US10016420, 8)
Affinity DataIC50: 103nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209585(US9273011, 6 | US10016420, 6)
Affinity DataIC50: 127nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209589(US9273011, 10 | US10016420, 10)
Affinity DataIC50: 211nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209583(US9273011, 4 | US10016420, 4)
Affinity DataIC50: 262nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209588(US9273011, 9 | US10016420, 9)
Affinity DataIC50: 343nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209593(US9273011, 14 | US10016420, 14)
Affinity DataIC50: 648nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209591(US9273011, 12 | US10016420, 12)
Affinity DataIC50: 1.16E+3nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209592(US9273011, 13 | US10016420, 13)
Affinity DataIC50: 1.54E+3nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetAutotaxin(Human)
Inhibitaxin

US Patent
LigandPNGBDBM209590(US9273011, 11 | US10016420, 11)
Affinity DataIC50: 2.01E+4nMAssay Description:The FS-3 assay to identify ATX inhibitors was preformed as follows: 3 μl of standard inhibitor and test compounds were added to an assay plate. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent